Prognostic Factors of Patients with Ovarian Yolk Sac Tumors: A Study in Chinese Patients

Abstract

Our study demonstrated that the 5-year overall survival rate of YST was 53.9% for the Liaoning Cancer Hospital & Institute, China. Cisplatin-based chemotherapy, chemotherapy courses, residual tumor size and ascites volume were independent prognosis factors.